One home blood draw. Forty-odd biomarkers. A plan that changes as your body does. Lifeforce wants the years before you get sick to finally count for something.
Somewhere right now a phlebotomist is ringing a doorbell. No waiting room, no fluorescent lighting, no clipboard asking for your insurance group number again. A few vials later, the blood goes to a lab, and within days a person sees a dashboard of themselves: hormones, metabolism, heart, micronutrients, the quiet machinery that keeps them upright. This is the ordinary morning Lifeforce was built to manufacture at scale.
Lifeforce is a health optimization and longevity-medicine company. It measures 40 to 50-plus biomarkers from a single at-home draw, hands the results to a clinician on a video call, assigns a coach to keep things moving, and then translates the numbers into things you can do - supplements matched to your chemistry, hormone protocols where they fit, medication when warranted, and lifestyle changes that are specific rather than inspirational.
Conventional medicine is very good at one thing: telling you when something has already broken. The annual physical, that quaint ritual, is mostly a search for disease that has already arrived. If your labs land inside a reference range built around the average sick-ish adult, you are sent home as a success story - even if you feel foggy, tired, and vaguely worse than you did five years ago.
That gap, between not-sick and actually-well, is the tension Lifeforce exists inside. Plenty of people in midlife are spinning their wheels with diet and workouts and supplements they read about online, with no idea which of their numbers to trust. The information exists; it is just scattered across labs that do not talk, doctors who are rushed, and a wellness internet allergic to evidence.
In 2021, four people decided the gap was a business, not just a complaint. Tony Robbins and Dr. Peter Diamandis - co-authors, with Robert Hariri, of the best-seller Life Force - teamed with operator and CEO Dugal Bain-Kim and co-founder Joel Jackson. The book argued that precision medicine was arriving faster than the public realized. The company is the more inconvenient sequel: turning a 600-page promise into something you can subscribe to.
The bet is unfashionably simple. If you measure the right things often enough, hand the data to a clinician, and pair it with a coach who calls when you drift, ordinary people will make better decisions about their own bodies. Not a hospital. Not a gym. A loop.
Lifeforce is less a single product than a circuit you stay inside. The diagnostic is the front door; the retests are the reason you keep coming back. Each piece exists so the next one has something to act on.
An at-home blood draw by a visiting phlebotomist, covering 40-50+ biomarkers across hormones, metabolism, organ function, cardiovascular risk, and micronutrients.
A roughly 45-minute video visit with a clinician to read your results and build a plan spanning supplements, hormones, peptides, pharmaceuticals, and lifestyle.
A dedicated coach who turns the plan into habits and checks in between tests - the human glue most health apps forget.
Formulations matched to your biomarker results rather than a one-size-fits-all multivitamin, with member pricing.
Clinician-guided access to hormone protocols and prescription medication where the data supports it.
Retests every quarter so the plan adapts as your numbers move. Health treated as a system, not a snapshot.
Skeptics are right to ask what backs the pitch. The honest answer is a mix of capital, credibility, and a model that gets more useful the longer you stay in it. The 2023 Series A was oversubscribed and led by serious venture firms; the cap table includes a four-time Olympic gold medalist who knows a thing or two about optimizing a body under pressure.
Reviewers tend to recommend Lifeforce to the same crowd: people frustrated with brain fog and fatigue, anyone whose primary-care experience ended in a shrug, and the fitness-and-nutrition tinkerers who want data instead of vibes. It is not free - public reports put the diagnostic in the few-hundred-dollar range with a monthly membership on top - and it is squarely aimed at people willing to pay to manage their health on offense.
Strip away the celebrity founders and the longevity buzzwords and the mission is almost dull in its sensibility: make data-driven health optimization accessible, so people can decide what to do about their bodies before something forces the issue. The stated ambition is to become the most effective health optimization platform in the world. The quieter ambition is to make the phrase "proactive medicine" mean something other than a marketing slide.
The whole longevity category lives with one risk: that it becomes expensive theater for the worried well, a spa with a lab attached. Lifeforce's answer is the loop - measure, interpret, act, retest - which only pays off if the numbers actually move and the advice actually lands. That is the bet investors funded, and the standard the company has set for itself.
So return to that phlebotomist on the doorstep. A few years ago that visit would have ended with results emailed into a void, a PDF nobody could read, filed next to good intentions. Now it is the first step of a plan that has a clinician's name on it, a coach attached to it, and a calendar reminder to do it all again in three months. The doorbell rings the same. What happens after it does not.